Sanofi announced as Insulin Safety Week sponsor
Insulin Safety Week 2023 participants
Leading global healthcare company Sanofi Healthcare announced as Insulin Safety Week 2024 sponsor – supporting efforts to reduce errors within the profession.
Created to raise awareness of insulin safety within the healthcare community, Insulin Safety Week returns this year with a focus on the safe use of diabetes technology – ensuring diabetes experts and non-specialists are fully prepared for the phased roll out of hybrid closed loop systems.
Providing diverse healthcare solutions across the UK and Ireland, Sanofi has sponsored Insulin Safety Week since 2016, helping to reduce challenges around insulin safety within UK and Ireland healthcare settings.
Debbie Woods, Head of Medical Sanofi General Medicines said: “Sanofi are delighted to support Insulin Safety week again in 2024.
“It’s of vital importance to Sanofi that insulin is used safely within the hospital setting for people living with diabetes who find themselves in hospital. With the advent of new technology and new ways of administering insulin which may not be well known by non-diabetes specialist staff working in a hospital, this is more important than ever to ensure that anyone admitted to hospital with diabetes does not suffer avoidable consequences as a result of an insulin error.”
Event manager Emily Mayhew said: “Insulin Safety Week is an important opportunity for healthcare staff to come together and strengthen their knowledge and understanding of insulin therapy.
“Free to take part and open to all healthcare professionals working in diabetes care, the campaign held July 1 to 7, will provide comprehensive resources to help increase understanding of the new technology.”
To register and find out more about Insulin Safety Week 2024, visit www.insulinsafetyweek.com.
Insulin Safety Week 2024 is organised by Orange Juice Communications and has been funded by Embecta, GlucoRx, Medtronic, Sanofi and Ypsomed which have had no input into any arrangements or content.